INTERRUPTION OF MATERNAL-FETAL TRANSMISSION OF HIV

阻断 HIV 母婴传播

• 批准号: 8357331
• 负责人: JOSEPH M MCCUNE
• 金额: $ 14.36万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-05-01 至 2012-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8357331
• 关键词: Address; California; Disease; Funding; Grant; HIV; Immune response; Interruption; Maternal-Fetal Transmission; National Center for Research Resources; Primates; Principal Investigator; Research; Research Infrastructure; Resources; Source; United States National Institutes of Health; Vaccination; Vaccines; Virus; cost; novel strategies; prevent

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. These studies address a novel approach towards vaccination against HIV disease, namely: to create a vaccine that will prevent, rather than to elicit, a robust immune response against the virus.

该副本是利用资源的众多研究子项目之一 由NIH/NCRR资助的中心赠款提供。对该子弹的主要支持 而且，副投影的主要研究员可能是其他来源提供的 包括其他NIH来源。 列出的总费用可能 代表subproject使用的中心基础架构的估计量， NCRR赠款不直接向子弹或副本人员提供的直接资金。 这些研究介绍了一种针对HIV疾病的新型方法，即：创建一种疫苗，可以防止而不是引起对病毒的强烈免疫反应。